|Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study|
GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ...
Journal of the American College of Cardiology 76 (25), 2982-3021, 2020
|Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy|
JN Johnson, C Grifoni, JM Bos, M Saber-Ayad, SR Ommen, S Nistri, ...
European heart journal 32 (9), 1114-1120, 2011
|Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program|
HS Kassem, RS Azer, MS Ayad, S Moharem-Elgamal, G Magdy, ...
Journal of cardiovascular translational research 6 (1), 65-80, 2013
|Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells|
RA El-Awady, MH Semreen, MM Saber-Ayad, F Cyprian, V Menon, ...
DNA repair 37, 1-11, 2016
|The rationale for potential pharmacotherapy of COVID-19|
M Saber-Ayad, MA Saleh, E Abu-Gharbieh
Pharmaceuticals 13 (5), 96, 2020
|DYRK1A: A down syndrome-related dual protein kinase with a versatile role in tumorigenesis|
AJ Laham, M Saber-Ayad, R El-Awady
Cellular and Molecular Life Sciences 78 (2), 603-619, 2021
|Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations|
WM Abdel-Rahman, NA Al-Khayyal, VA Nair, SR Aravind, M Saber-Ayad
World journal of gastroenterology 23 (19), 3440, 2017
|The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells|
F Alam, F Mezhal, H El Hasasna, VA Nair, SR Aravind, M Saber Ayad, ...
Tumor Biology 39 (9), 1010428317714634, 2017
|Angiotensin-converting enzyme I/D gene polymorphism affects early cardiac response to professional training in young footballers|
MM Saber-Ayad, YS Nassar, IA Latif
Journal of the Renin-Angiotensin-Aldosterone System 15 (3), 236-242, 2014
|Antibiotic misuse in different hospital wards (a pilot study in an Egyptian hospital)|
OM Ibrahim, M Saber-Ayad
Asian J Pharm Clin Res 5 (2), 95-7, 2012
|The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019|
The Lancet Oncology 23 (1), 27-52, 2022
|Tandem multicomponent reactions toward the design and synthesis of novel antibacterial and cytotoxic motifs|
M H Semreen, R El-Awady, R Abu-Odeh, M Saber-Ayad, ...
Current medicinal chemistry 20 (11), 1445-1459, 2013
|The FTO rs9939609 “A” allele is associated with impaired fasting glucose and insulin resistance in Emirati population|
M Saber-Ayad, S Manzoor, A El Serafi, I Mahmoud, S Hammoudeh, ...
Gene 681, 93-98, 2019
|Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism on steroid resistance in Egyptian children with idiopathic nephrotic syndrome|
M Saber-Ayad, S Sabry, I Abdel-Latif, H Nabil, SA El-Azm, S Abdel-Shafy
Journal of the Renin-Angiotensin-Aldosterone System 11 (2), 111-118, 2010
|Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019|
E Cousin, BB Duncan, C Stein, KL Ong, T Vos, C Abbafati, ...
The Lancet diabetes & endocrinology 10 (3), 177-192, 2022
|Histone modification in NSCLC: molecular mechanisms and therapeutic targets|
K Bajbouj, A Al-Ali, RK Ramakrishnan, M Saber-Ayad, Q Hamid
International journal of molecular sciences 22 (21), 11701, 2021
|A mixed methods approach to determine the climate of interprofessional education among medical and health sciences students|
N Sulaiman, Y Rishmawy, A Hussein, M Saber-Ayad, H Alzubaidi, ...
BMC medical education 21 (1), 1-13, 2021
|The FTO genetic variants are associated with dietary intake and body mass index amongst Emirati population|
M Saber-Ayad, S Manzoor, H Radwan, S Hammoudeh, R Wardeh, ...
Plos one 14 (10), e0223808, 2019
|Functional G1199A ABCB1 polymorphism may have an effect on cyclosporine blood concentration in renal transplanted patients|
G Mostafa‐Hedeab, MM Saber‐Ayad, IA Latif, SO Elkashab, ...
The Journal of Clinical Pharmacology 53 (8), 827-833, 2013
|PRMT5 selective inhibitor enhances therapeutic efficacy of cisplatin in lung cancer cells|
K Bajbouj, RK Ramakrishnan, M Saber-Ayad, HA Omar, ...
International Journal of Molecular Sciences 22 (11), 6131, 2021